Home > Products > API > Tubulysin A
Tubulysin A
  • Tubulysin ATubulysin A

Tubulysin A

Product Name: Tubulysin A
Formulae hypotheticae: C43H65N5O10S
M. Pondus: 844.07
CAS Subcriptio Number; 205304-86-5

Model:CAS NO:205304-86-5

Mitte Inquisitionem

depictio producti

Tubulysin A

Product nomen:Tubulysin A 205304-86-5
CAS No:205304-86-5
Specification: in domo

Nomen Tubulysin A
Synonyma TubA;TubulysinA;TubulysinA,TubA;TubulysinsA;CS-1324;Benzenepentanoicacid,γ-[[[2-[(1R,3R)-1-(acetyloxy)-4-methyl-3-[[(2S,3S)- 3-methyl-2 -[[[[(2R)-1-methyl-2-piperidinyl]carbonyl]amino]-1-oxopentyl][(3-methyl-1-oxobutoxy)methyl]amino]pentyl]-4-thiazolyl]carbonyl]aminChemic albooko] -4-hydroxy-α-methyl-,(αS,γR)-;(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-4-methyl-3-[3 -methylbutanoyloxymethyl-[(2S,3S)-3-methyl-2-[[( 2R)-1-methylpiperidine-2-carbonyl]amino]pentanoyl]amino]pentyl]-1,3-thiazole-4-carbonyl]amino]-5-(4-hydroxyphenyl)-2-methylpentanoicaci
copyRight
M. Structure CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C43H65N5O10S
M. Pondus 844.07
CAS Subcriptio Number 205304-86-5


Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Tubulysin A, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept